Clinical Trial Update: A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

A multicenter, open-label Phase I trial evaluating the safety and pharmacokinetics of TQB2252 Injection in adults with advanced malignant tumors; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB2252 Injection (TQB2252)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. | Conditions: Advanced Cancers | Phase 1 | Status: NOT_YET_RECRUITING